OrbusNeich Medical Group Holdings Ltd
06929: XHKG (HKG)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
HK$6.15 | Wppbj | Cqvrtjm |
OrbusNeich: Initiating Coverage of Chinese Coronary Balloon Maker With HKD 9.40 Fair Value Estimate
We initiate coverage on OrbusNeich Medical Group with a no-moat rating and a fair value estimate of HKD 9.40 per share. We view it as fairly valued right now. We think the stock is worth watching over the next five years as it expands its product offerings. We expect OrbusNeich’s EPS to grow at a five-year CAGR of 13.6%.